Literature DB >> 24700926

Profiling and hormonal therapy for acne in women.

Sangita Ghosh1, Soumik Chaudhuri2, Vijay Kumar Jain1, Kamal Aggarwal1.   

Abstract

Acne vulgaris is the most common condition treated by physicians worldwide. Though most acne patients remit spontaneously, for the ones that do not or are unresponsive to conventional therapy or have obvious cutaneous signs of hyperandrogenism, hormonal therapy is the next option in the therapeutic ladder. It is not strictly indicated for only those patients who have cutaneous or biochemical evidence of hyperandrogenism, but can be used even without any evidence of hyperandrogenism, for therapy-resistant acne. It can be prescribed as monotherapy, but when used in combination with other conventional therapies, it may prove to be more beneficial. Hormonal evaluation is a prerequisite for hormonal therapy, to identify the cause behind hyperandrogenism, which may be ovarian or adrenal. This article reviews guidelines for patient selection and the various available hormonal therapeutic options, their side-effect profile, indications and contraindications, and various other practical aspects, to encourage dermatologists to become comfortable prescribing them.

Entities:  

Keywords:  Acne; hormonal therapy; hyperandrogenism

Year:  2014        PMID: 24700926      PMCID: PMC3969667          DOI: 10.4103/0019-5154.127667

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


  57 in total

1.  Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.

Authors:  William Koltun; J Michael Maloney; Joachim Marr; Michael Kunz
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-02-02       Impact factor: 2.435

Review 2.  Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.

Authors:  M Costello; B Shrestha; J Eden; P Sjoblom; N Johnson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield
Journal:  Endocr Rev       Date:  1995-06       Impact factor: 19.871

Review 4.  New understandings of the pathogenesis of acne.

Authors:  J J Leyden
Journal:  J Am Acad Dermatol       Date:  1995-05       Impact factor: 11.527

5.  Oral spironolactone improves acne vulgaris and reduces sebum excretion.

Authors:  A Goodfellow; J Alaghband-Zadeh; G Carter; J J Cream; S Holland; J Scully; P Wise
Journal:  Br J Dermatol       Date:  1984-08       Impact factor: 9.302

6.  Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.

Authors:  T Kazerooni; M Dehghan-Kooshkghazi
Journal:  Gynecol Endocrinol       Date:  2003-02       Impact factor: 2.260

7.  Should dermatologists prescribe hormonal contraceptives for acne?

Authors:  Julie C Harper
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

8.  The effect of tetracycline on levels of oral contraceptives.

Authors:  A A Murphy; H A Zacur; P Charache; R T Burkman
Journal:  Am J Obstet Gynecol       Date:  1991-01       Impact factor: 8.661

9.  [Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women].

Authors:  J B Schmidt; A Lindmaier; J Spona
Journal:  Hautarzt       Date:  1991-03       Impact factor: 0.751

10.  Treatment with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism.

Authors:  E Faloia; S Filipponi; V Mancini; P Morosini; R De Pirro
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

View more
  4 in total

1.  Clinical, Biochemical, and Hormonal Associations in Female Patients with Acne: A Study and Literature Review.

Authors:  Sujata Mehta-Ambalal
Journal:  J Clin Aesthet Dermatol       Date:  2017-10-01

Review 2.  Features of Polycystic Ovary Syndrome in adolescence.

Authors:  P Tsikouras; L Spyros; B Manav; S Zervoudis; C Poiana; T Nikolaos; P Petros; M Dimitraki; C Koukouli; G Galazios; G F von Tempelhoff
Journal:  J Med Life       Date:  2015 Jul-Sep

3.  Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.

Authors:  Duru Shah; Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2018 Apr-Jun

Review 4.  Hormonal treatment of acne vulgaris: an update.

Authors:  Mohamed L Elsaie
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.